U-Neuron Biomedical (ROCO:6973) EPS (Diluted): NT$-1.42 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
12 GF Score
Price NT$32.80
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical EPS (Diluted)?

U-Neuron Biomedical ROCO:6973 +0.15% 12 EPS (Diluted) is NT$-1.42 as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

U-Neuron Biomedical's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was NT$-0.82. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.42.

U-Neuron Biomedical's EPS (Basic) for the six months ended in Dec. 2025 was NT$-0.82. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.42.

U-Neuron Biomedical's EPS without NRI for the six months ended in Dec. 2025 was NT$-0.82. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.42.

During the past 3 years, the average EPS without NRIGrowth Rate was 19.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, U-Neuron Biomedical's highest 3-Year average EPS without NRI Growth Rate was 19.30% per year. The lowest was -23.70% per year. And the median was -2.20% per year.

U-Neuron Biomedical  (ROCO:6973) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

U-Neuron Biomedical EPS (Diluted) Related Terms

U-Neuron Biomedical EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical EPS (Diluted) Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Diluted)
Get a 7-Day Free Trial -0.93 -2.70 -3.42 -1.76 -1.42

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.62 -1.09 -0.67 -0.60 -0.82

ROCO:6973 vs VRTX, REGN, ALNY: EPS (Diluted) Comparison

For the Biotechnology subindustry, U-Neuron Biomedical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's PE Ratio distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's PE Ratio falls into.


ROCO:6973
12GF Score
U-Neuron Biomedical Inc ROCO:6973
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

U-Neuron Biomedical's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-55.294-0)/38.863
=-1.42

U-Neuron Biomedical's Diluted EPS for the quarter that ended in Dec. 2025 is calculated as

Diluted EPS (Q: Dec. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-31.819-0)/38.545
=-0.83

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of NT$-1.42 mean?
U-Neuron Biomedical (ROCO:6973) has a EPS (Diluted) of NT$-1.42 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on U-Neuron Biomedical and its competitors.
Is U-Neuron Biomedical's EPS (Diluted) too high?
U-Neuron Biomedical's current EPS (Diluted) is NT$-1.42. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's EPS (Diluted) compare to VRTX and REGN?
U-Neuron Biomedical's EPS (Diluted) of NT$-1.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current EPS (Diluted) is NT$-1.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current EPS (Diluted) of NT$-1.42. The current EPS (Diluted) is NT$-1.42. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current EPS (Diluted) is NT$-1.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score

Get the complete analysis for ROCO:6973

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.80
Price